2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Highlights on Recurred/Metastatic ACC: Does Axitinib Increase PFS Rate Compared to Observation? How Does Tipifarnib Affect H&N Tumors With HRAS Mutations?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Michael Gibson
By 2020 ASCO Virtual Direct™ Highlights FEATURING Michael Gibson
14 views
September 29, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

04:43
Treatment Approach for Advanced Ovarian Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
Head&Neck
06:49

2020 ASCO Updates on Locally Advanced Oropharynx Cancer: Can Surgery…

2020 ASCO Virtual Direct™ Highlights

M. Gibson

11 views
06:02

2020 ASCO Highlights on HNSCC: Weekly vs. 3-Weekly Cisplatin - What …

2020 ASCO Virtual Direct™ Highlights

M. Gibson

19 views
08:48

2020 ASCO Highlights on Recurred/Metastatic ACC: Does Axitinib Incre…

2020 ASCO Virtual Direct™ Highlights

M. Gibson

14 views